Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Short Interest Update

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) was the recipient of a large decrease in short interest during the month of January. As of January 15th, there was short interest totaling 21,391 shares, a decrease of 32.6% from the December 31st total of 31,742 shares. Based on an average daily volume of 20,233 shares, the days-to-cover ratio is presently 1.1 days. Currently, 0.0% of the shares of the company are short sold. Currently, 0.0% of the shares of the company are short sold. Based on an average daily volume of 20,233 shares, the days-to-cover ratio is presently 1.1 days.

Zhengye Biotechnology Stock Up 4.0%

Shares of NASDAQ:ZYBT opened at $0.98 on Monday. The stock has a 50 day moving average of $1.55 and a 200 day moving average of $3.93. Zhengye Biotechnology has a 12-month low of $0.90 and a 12-month high of $14.30. The company has a current ratio of 1.49, a quick ratio of 1.10 and a debt-to-equity ratio of 0.01.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Zhengye Biotechnology in a report on Friday, January 9th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Zhengye Biotechnology presently has an average rating of “Sell”.

Institutional Trading of Zhengye Biotechnology

Several institutional investors and hedge funds have recently modified their holdings of ZYBT. Geode Capital Management LLC purchased a new position in shares of Zhengye Biotechnology during the 2nd quarter valued at $174,000. Invesco Ltd. bought a new stake in Zhengye Biotechnology during the second quarter valued at about $220,000. Jane Street Group LLC bought a new stake in Zhengye Biotechnology during the second quarter valued at about $1,158,000. WINTON GROUP Ltd purchased a new position in shares of Zhengye Biotechnology in the third quarter valued at about $56,000. Finally, Citadel Advisors LLC bought a new position in shares of Zhengye Biotechnology in the third quarter worth about $31,000.

Zhengye Biotechnology Company Profile

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.